Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells.
A prominent functional change during differentiation of lutein cells from follicular thecal and granulosa cells is an enhanced production and secretion of progestins. The regulation of this process is not fully understood but may be associated with the expression of transcription factors which activate genes, products of which are involved in pathways of the cholesterol and lipid metabolism. As peroxisome proliferator-activated receptors (PPARs) play a role in both pathways, we were interested in the expression of PPARgamma, a PPAR form which is involved in adipogenic differentiation. First, we were able to show the expression of PPARgamma in bovine lutein cells (day 12 of the ovarian cycle) at the mRNA and protein level by imaging, flow cytometry and blot analysis, and secondly a role of PPARgamma in the secretion of progesterone. The cells (24 h culture) responded dose dependently by increasing progesterone secretion (up to 1.5-fold of the basal level) to an endogenous ligand of PPARgamma, 15-deoxy-delta12,14 prostaglandin J2 (15-dPGJ2) and to the thiazolidinedione ciglitizone. Aurintricarboxylic acid (ATA) was found to reduce the intracellular PPARgamma level and to promote cell cycle progress, indicating that ATA can be used as a tool for experimental changes of PPARgamma proteins in intact cells and for studying the physiological consequences. The ATA-mediated decrease of PPARgamma was accompanied by reduced progesterone production and a progression of the cell cycle, suggesting a function of PPARgamma in both processes. The response to ATA was abrogated by a high dose (>490 nM) of 15-dPGJ2, suggesting that 15-dPGJ2 exerts its effect on steroidogenic activity via PPARgamma and that the 15-dPGJ2-PPARgamma system plays a role in the maintenance of a differentiated quiescent stage in lutein cells.
Löhrke
B
B
Research Institute of Animal Biology Dummerstorf-Rostock, Wilhelm-Stahl-Allee 2, D-18196 Dummerstorf, Germany.
Viergutz
T
T
Shahi
S K
SK
Pöhland
R
R
Wollenhaupt
K
K
Goldammer
T
T
Walzel
H
H
Kanitz
W
W
D000704:Analysis of Variance; D000818:Animals; D001312:Aurintricarboxylic Acid / Q000494:pharmacology; D002417:Cattle; D002453:Cell Cycle / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D005434:Flow Cytometry; D006107:Granulosa Cells / Q000737:chemistry / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology; D008184:Luteal Cells / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism; D007986:Luteinizing Hormone / Q000378:metabolism; D008856:Microscopy, Fluorescence; D011374:Progesterone / Q000378:metabolism; D015230:Prostaglandin D2 / Q000031:analogs & derivatives / Q000494:pharmacology; D020033:Protein Isoforms / Q000032:analysis / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D018160:Receptors, Cytoplasmic and Nuclear / Q000032:analysis* / Q000235:genetics / Q000378:metabolism; D011974:Receptors, LH / Q000378:metabolism; D013844:Thiazoles / Q000494:pharmacology; D045162:Thiazolidinediones; D014157:Transcription Factors / Q000032:analysis* / Q000235:genetics / Q000378:metabolism
C097240:15-deoxy-delta(12,14)-prostaglandin J2; D007004:Hypoglycemic Agents; D020033:Protein Isoforms; D012333:RNA, Messenger; D018160:Receptors, Cytoplasmic and Nuclear; D011974:Receptors, LH; D013844:Thiazoles; D045162:Thiazolidinediones; D014157:Transcription Factors; D001312:Aurintricarboxylic Acid; D011374:Progesterone; D007986:Luteinizing Hormone; D015230:Prostaglandin D2; C039671:ciglitazone